Obinutuzumab (Gazyva)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Obinutuzumab (Gazyva), covering 2015-09-22 to 2025-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies [Phase 1]